Parotid Gland Enlargement in Pediatric HIV Population

Objectives: To establish the significance of parotid enlargement, state frequency, cytological features and effect of antiretroviral therapy (ART) on parotid enlargement among a pediatric HIV population. Study design: A 6 month cross sectional survey that utilised clinical features, serial immunological indices and fine needle aspiration cytology. Results: 287 HIV positive children were seen at special paediatric clinic of the University College Hospital, Ibadan, Nigeria, 114 (39.7%) had oral features and among these 24 (8.4%) had parotid involvement comprising of 10 males and 14 females. The overall mean age was 43.4 + 39.7 months compared with 59.6 + 36.5 months in the parotid enlargement group (p = 0.03). Mean ages of parotid enlargement and non enlargement group was significantly different (p = 0.03). The mode of transmission was vertical in (91.7%), 87.5% was bilateral (87.5%) and (75%) presented as a syndrome state with generalised lymphadenopathy. The predominant cytology was lymphoid hyperplasia (62.5%). ART resulted in marked clinical reduction in all the cases and statistically significant improvement in serum indices of CD4 count, CD4% and viral load (p = 0.001, 0.000 & 0.009 respectively). Conclusion: HIV positive children often present with bilateral parotid enlargement and the syndrome state with classical clinical and cytological features of lymphoid hyperplasia predominated. ART resulted in satisfactory reduction of the swellings in most of the cases with no need for further intervention.

Parotid gland enlargement, Syndrome, HIV,children.

1. Mandel L, Surattanont F. Regression of HIV parotid swellings after anti-viral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 454-9, 2002.

2. Morales-Aguirre JJ, Patino-Nino AP, Mendoza-Azpiri M, et al. Parotid cysts in children infected with human immunodeficiency virus. Arch Otolaryngol Head Neck Surg 131: 353–355, 2005.

3. Patton LL, Vander Horst. Oral infections and mainfestations of HIV disease. Infect Dis Clin North Am 13: 879-900, 1999.

4. Matee MI, Scheutz F, Moshy J. Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 6: 106-111, 2000.

5. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a compar-ative study of institutionalized and hospital outpatients. Oral Dis 10: 13-18, 2004.

6. Morris MR, Moore DW, Shearer GL. Bilateral multiple benign lymphoep-ithelial cysts of the parotid gland. OtolaryngolHead Neck Surg 97: 87–90, 1987.

7. Weidner N, Geisinger KR, Sterling RT, Miller TR, Yen TS. Benign lympho-epithelial cysts of the parotid gland. A histologic, cytologic, and ultrastruc-tural study. Am J Clin Pathol 85: 395–401, 1986.

8. Ryan JR, Ioachim HL, Marmer J, Loubeau JM. Acquired immune defi-ciency syndrome-related lymphadenopathies presenting in the salivary gland nodes. Arch Otolaryngol 111: 554–556, 1985.

9. Shugar JM, Som PM, Jacobson AL, Ryan JR, Bernard PJ, Dickman SH. Multicentric parotid cysts and cervical adenopathy in AIDS patients. A newly recognized entity: CT and MR manifestations. Laryngoscope 98: 772–775, 1988.

10. Steehler MK, Steehler MW, Davison SP. Benign lymphoepithelial cysts of the parotid: long-term surgical results HIV/AIDS - Research and Palliative Care 4: 81–8, 2012.

11. Levay PF, Botes ME. Diffuse infliterative lymphocytosis syndrome. SA Fam Pract 50 : 42-44, 2008.

12. Tripathi AK, Gupta N, Ahmad R, Bhandari HS, Kalra P.HIV disease presenting as parotid lymphoepithelial cysts: a presumptive diagnosis of diffuse infiltrative lymphocytic syndro me (DILS). J Assoc Physicians India 52: 921-3, 2004.

13. Lepage P, van de Pere P, Dabis F, Commeages De Orbinski J, Hitima DG, et al. Evaluation and simplification of the World Health Organization clinical case definition for Pediatric AIDS. AIDS 3: 221-225, 1989.

14. Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson S, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immuno-deficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 112: 3-10, 1990.

15. Ranganathan K, Geethalakshmi E, Rao UK , Vidya KM, Kumarasamy N, Solomon S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. International Journal of Paediatric Dentistry 20: 276 – 282, 2010.

16. Glick M. Orofacial disorders in children with HIV disease. DCNA 4: 259–271, 2005.

17. Soberman N, Leonidas JC, Berdon WE, Bonagura V, HaIler JO, Posner M, Mandel L. Parotid Enlargement in Children Seropositive for Human Immunodeficiency Virus: Imaging Findings. AJR 157: 553-556, 1991.

18. Dave SP, Pernas FG, Roy S. The Benign Lymphoepithelial Cyst and a Classification System for Lymphocytic Parotid Gland Enlargement in the Pediatric HIV Population. Laryngoscope 117: 106–113, 2007.

19. World Health Organization. WHO Case Definitions of HIV for Surveil-lance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children, Geneva; 29 –37 2007.

20. Mothi SN , Karpagam S, Swamy VHT, Lala Mamatha M, Sarvode SM. Paediatric HIV - trends & challenges Indian J Med Res 134: 912-919, 2011.

21. Behrman R, Kleigman R, Jenson H. Nelson textbook of pediatrics. 18th ed. Philadelphia: W.B. Saunders Company; 2007.

22. Rivera H, Nikitalis NG, Castillo S, Siavash H, Papadimitriou JC, Sauk JJ. Histopathological analysis and demonstration of EBV and HIV-p2 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome. J Oral Pathol Med 32: 431-7, 2003.

23. Franco-Paredes C, Rebolledo P, Folch E, Hernandez I, del Rio C. Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read 12: 408-13, 2002.

24. Favia G, Capodiferro S, Scivetti M, Lacaita MG, Filosa A, Muzio LL. Multiple parotid lymphoepithelial cysts in patients with HIV-infection: report of two cases. Oral Dis 10:151–154, 2004.

25. Layfield LJ, Gopez EV. Cystic lesions of the salivary glands: cytological features of fine needle aspiration biopsies. Diagn Cytopathol 27: 197–204, 2002.

26. Hviid A, Rubin S, Muhlemann K; Mumps. Lancet 371 :932-44, 2008.

27. Tauro LF, George C, Kamath A, et al; Primary tuberculosis of submandib-ular salivary gland. J Glob Infect Dis 3(1): 82-5, 2011.

28. Ioachim HL, Rateeh H. Human immunodeficiency virus lymphadenitis of salivary gland. In. Ioachim lymph node pathology. 3rd ed. Philadephia: Lippincott. Williams andWilkins: 2002. P. 104-6.

29. Tiwari A, Kini H, Pai RR, Rau RA. HIV lymphadenitis of the salivary gland: A case with cytological and histological correlation. J Cytol 26(4): 146–148, 2009.

30. Som PM, Brandwein MS, Silvers A. Nodal inclusion cysts of the parotid gland and parapharyngeal space: A discussion of lymphoepithelial, AIDS-related parotid, and branchial cysts, cystic Warthin’s tumors, and cysts in Sjogren’s syndrome. Laryngoscope 105: 1122-8, 1995.

31. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin North Am 18: 683-97, 1992.

32. Young JA, Warfield AT. The salivary glands in: Gray W, McKee GT editors, Diagnostic Cytopathology 2nd Ed. London: Churchill Livingstone; 305 – 23, 2003.

33. Gottesman RI, Som PM, Mester J, Silvers A. Observations on two cases of apparent submandibular gland cysts in HIV positive patients: MR and CT findings. J Comput Assist Tomogr 20: 444-7, 1996.

34. Papiris SA, Saetta M, Turato G, La Corte R, Trevisani L, Mapp CE, Maestrelli P, Fabbri LM, Potena A. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren’s syndrome. Am J Respir Crit Care Med.156 : 637-41, 1997.

35. Pender PW. CD8+ T-Cell deficiency, Epstein-Barr virus infection, Vitamin D deficiency, and steps to Autoimmunity: A Unifying Hypothesis. Autoim-mune diseases 2: 1-16, 2012.

36. Wladis EJ, Kapila R, Chu DS. Idiopathic CD4 Lymphocytopenia and Sjogren’s syndrome. Archives of Opthamology 23: 1012, 2005.

37. Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18: 389–395, 2006.

38. Smith MC, Zimmerman MB, Burke DK, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119: 107–115, 2009.